Kezar Life Sciences (KZR)
(Delayed Data from NSDQ)
$0.67 USD
+0.02 (3.60%)
Updated Jul 17, 2024 09:52 AM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.32 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | 11.76% |
ABR | 1.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.24 |
Next Year | -1.27 |
EPS (TTM) | -1.31 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.00M | 4.00M | 12.00M | 20.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 3.00M | 4.00M | 12.00M | 20.00M |
Low Estimate | 3.00M | 4.00M | 12.00M | 20.00M |
Year ago Sales | 0.00M | 7.00M | 7.00M | 12.00M |
Year over Year Growth Est. | NA | -42.86% | 71.43% | 66.67% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.32 | -0.31 | -1.24 | -1.27 |
# of Estimates | 4 | 3 | 4 | 4 |
Most Recent Consensus | -0.26 | -0.23 | -0.98 | -0.85 |
High Estimate | -0.26 | -0.23 | -0.98 | -0.85 |
Low Estimate | -0.36 | -0.37 | -1.36 | -1.58 |
Year ago EPS | -0.34 | -0.32 | -1.31 | -1.24 |
Year over Year Growth Est. | 5.88% | 3.13% | 5.34% | -2.42% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.32 | -0.31 | -1.24 | -1.27 |
7 Days Ago | -0.32 | -0.31 | -1.24 | -1.27 |
30 Days Ago | -0.32 | -0.31 | -1.24 | -1.27 |
60 Days Ago | -0.32 | -0.31 | -1.24 | -1.27 |
90 Days Ago | -0.31 | -0.31 | -1.26 | -1.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.32 | -0.31 | -1.24 | -1.27 |
Zacks Consensus Estimate | -0.32 | -0.31 | -1.24 | -1.27 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.35 | -0.32 | -0.34 | NA |
Estimate | -0.34 | -0.39 | -0.36 | -0.33 | NA |
Difference | 0.04 | 0.04 | 0.04 | -0.01 | 0.03 |
Surprise | 11.76% | 10.26% | 11.11% | -3.03% | 7.53% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more